Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-042278
Filing Date
2017-06-29
Accepted
2017-06-29 16:16:58
Documents
1
Period of Report
2017-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4085
  Complete submission text file 0001209191-17-042278.txt   5438
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CREDIT SUISSE PRIVATE EQUITY INC 11 MADISON AVE NEW YORK NY 10010
Business Address
NIEDEL JAMES (Reporting) CIK: 0001231092 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35867 | Film No.: 17938513